country(3) Favipiravir(3) identify(3) Severe acute respiratory syndrome(3) exhibited(3) information(3) Analysis(3) Pharmaceutical Preparation(3) Treatment(3) quantitation(3) biological fluid(3) coronavirus(3) fluorescence intensity(3) coronavirus 2(3) investigated(3) harmonization(3) were measured(3) Acetate(3) Interference(3) Drug administration(3) United States Food and Drug Administration(3) viral infection(3) limit(3) drug(3) caused(3) sensitivity(3) condition(3) pharmaceutical preparations(3) biological fluids(3) acute respiratory syndrome(3)